Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
Year: 2025
Type: article
Abstract: Widespread delivery of therapeutic proteins to the brain remains challenging. To determine whether human induced pluripotent stem cell (iPSC)-microglia (iMG) could enable brain-wide and pathology-responsive delivery of therapeutic cargo, we utilized CRISPR gene editing to engineer iMG to express the Aβ-degrading enzyme neprilysin under control of the plaque-responsive promoter, CD9. To further determine whether increased engraftment enhances efficacy, we utilized a CSF1R-inhibitor resistance approach. Interestingly, both localized and brain-wide engraftment in Alzheimer's disease (AD) mice reduced multiple biochemical measures of pathology. However, within the plaque-dense subiculum, reductions in plaque load, dystrophic neurites, and astrogliosis and preservation of neuronal density were only achieved following widespread microglial engraftment. Lastly, we examined chimeric models of breast cancer brain metastases and demyelination, demonstrating that iMG adopt diverse transcriptional responses to differing neuropathologies, which could be harnessed to enable widespread and pathology-responsive delivery of therapeutics to the CNS.
Source: Cell stem cell
Authors: Jean Paul Chadarevian, Hayk Davtyan, Alina L. Chadarevian, Jasmine Nguyen, Joia K. Capocchi, Lauren Le, Adrian Escobar, Talar Chadarevian, Kimiya Mansour, Ekaterina Deynega, Michael Mgerian, Christina Tu, Sepideh Kiani Shabestari, William Carlen-Jones, Ghazaleh Eskandari-Sedighi, Jonathan Hasselmann, Robert C. Spitale, Mathew Blurton-Jones
Institution: University of California, Irvine
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $10,400
Awards: The role of TREM2 in human microglial function and Alzheimer disease pathogenesis, G12099775, G1281022434, A novel platform for the investigation of human microglia, Examining the role of adaptive immunity in Alzheimer's Disease pathogenesis, Optimizing the differentiation and expansion of microglial progenitors from human pluripotent stem cells for the study and treatment of neurological disease., ENGINEERED HUMAN MICROGLIA AS A CELL-BASED THERAPY FOR A-BETA PLAQUE REMOVAL, G501437852, G6143810018, G7146800030, G7325866574, Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease, G7843301214, Assessing cell specific proteomes in the presence and absence of C5a complement signaling in Alzheimer's disease models, G9000106966, G9000340509, Training in the Neurobiology of Aging and Alzheimers Disease, Training in Translational ADRD Neuroscience (TITAN), The Alzheimer's Disease Research Center at the University of California, Irvine, Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
OpenAlex ID: W4409412562
